Literature DB >> 19153226

Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles.

François-Loic Cosset1, Philippe Marianneau, Geraldine Verney, Fabrice Gallais, Noel Tordo, Eve-Isabelle Pécheur, Jan ter Meulen, Vincent Deubel, Birke Bartosch.   

Abstract

The cell entry and humoral immune response of the human pathogen Lassa virus (LV), a biosafety level 4 (BSL4) Old World arenavirus, are not well characterized. LV pseudoparticles (LVpp) are a surrogate model system that has been used to decipher factors and routes involved in LV cell entry under BSL2 conditions. Here, we describe LVpp, which are highly infectious, with titers approaching those obtained with pseudoparticles displaying G protein of vesicular stomatitis virus and their the use for the characterization of LV cell entry and neutralization. Upon cell attachment, LVpp utilize endocytic vesicles for cell entry as described for many pH-dependent viruses. However, the fusion of the LV glycoproteins is activated at unusually low pH values, with optimal fusion occurring between pH 4.5 and 3, a pH range at which fusion characteristics of viral glycoproteins have so far remained largely unexplored. Consistent with a shifted pH optimum for fusion activation, we found wild-type LV and LVpp to display a remarkable resistance to exposure to low pH. Finally, LVpp allow the fast and quantifiable detection of neutralizing antibodies in human and animal sera and will thus facilitate the study of the humoral immune response in LV infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19153226      PMCID: PMC2655582          DOI: 10.1128/JVI.01711-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

Review 1.  Arenaviruses: protein structure and function.

Authors:  M J Buchmeier
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

2.  Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV).

Authors:  Carmen M Ruiz-Jarabo; Calvin Ly; Esteban Domingo; Juan Carlos de la Torre
Journal:  Virology       Date:  2003-03-30       Impact factor: 3.616

3.  Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.

Authors:  Michael Garbutt; Ryan Liebscher; Victoria Wahl-Jensen; Steven Jones; Peggy Möller; Ralf Wagner; Viktor Volchkov; Hans-Dieter Klenk; Heinz Feldmann; Ute Ströher
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 4.  Lassa virus.

Authors:  Stephan Günther; Oliver Lenz
Journal:  Crit Rev Clin Lab Sci       Date:  2004       Impact factor: 6.250

5.  Hemolytic activity of influenza virus hemagglutinin glycoproteins activated in mildly acidic environments.

Authors:  S B Sato; K Kawasaki; S Ohnishi
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

6.  Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus.

Authors:  Igor S Lukashevich; Mahmoud Djavani; Juan D Rodas; Juan C Zapata; Amy Usborne; Carol Emerson; Jacque Mitchen; Peter B Jahrling; Maria S Salvato
Journal:  J Med Virol       Date:  2002-06       Impact factor: 2.327

7.  The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH.

Authors:  Laurie J Earp; Sue E Delos; Robert C Netter; Paul Bates; Judith M White
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

8.  Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin.

Authors:  P B Jahrling
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327

9.  Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.

Authors:  Virginie Sandrin; Bertrand Boson; Patrick Salmon; Wilfried Gay; Didier Nègre; Roger Le Grand; Didier Trono; François-Loïc Cosset
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

10.  Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.

Authors:  Birke Bartosch; Jean Dubuisson; François-Loïc Cosset
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

View more
  26 in total

1.  A Proteomics Survey of Junín Virus Interactions with Human Proteins Reveals Host Factors Required for Arenavirus Replication.

Authors:  Christopher M Ziegler; Philip Eisenhauer; Jamie A Kelly; Loan N Dang; Vedran Beganovic; Emily A Bruce; Benjamin R King; David J Shirley; Marion E Weir; Bryan A Ballif; Jason Botten
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 2.  Lassa Virus Cell Entry Reveals New Aspects of Virus-Host Cell Interaction.

Authors:  Giulia Torriani; Clara Galan-Navarro; Stefan Kunz
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

3.  Role of LAMP1 Binding and pH Sensing by the Spike Complex of Lassa Virus.

Authors:  Hadas Cohen-Dvashi; Hadar Israeli; Orly Shani; Aliza Katz; Ron Diskin
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

4.  Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses.

Authors:  W W Shanaka I Rodrigo; Juan C de la Torre; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

Review 5.  Structure-function relationship of the mammarenavirus envelope glycoprotein.

Authors:  Wei Wang; Zheng Zhou; Leike Zhang; Shaobo Wang; Gengfu Xiao
Journal:  Virol Sin       Date:  2016-08-04       Impact factor: 4.327

6.  Role of DC-SIGN in Lassa virus entry into human dendritic cells.

Authors:  Ana-Rita Goncalves; Marie-Laurence Moraz; Antonella Pasquato; Ari Helenius; Pierre-Yves Lozach; Stefan Kunz
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

7.  Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus.

Authors:  Hideki Tani; Koichiro Iha; Masayuki Shimojima; Shuetsu Fukushi; Satoshi Taniguchi; Tomoki Yoshikawa; Yoshihiro Kawaoka; Naoe Nakasone; Haruaki Ninomiya; Masayuki Saijo; Shigeru Morikawa
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

8.  Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis.

Authors:  Joel Oppliger; Giulia Torriani; Antonio Herrador; Stefan Kunz
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

9.  Virus entry. Lassa virus entry requires a trigger-induced receptor switch.

Authors:  Lucas T Jae; Matthijs Raaben; Andrew S Herbert; Ana I Kuehne; Ariel S Wirchnianski; Timothy K Soh; Sarah H Stubbs; Hans Janssen; Markus Damme; Paul Saftig; Sean P Whelan; John M Dye; Thijn R Brummelkamp
Journal:  Science       Date:  2014-06-27       Impact factor: 47.728

10.  Mutational Analysis of Lassa Virus Glycoprotein Highlights Regions Required for Alpha-Dystroglycan Utilization.

Authors:  Marissa Acciani; Jacob T Alston; Guohui Zhao; Hayley Reynolds; Afroze M Ali; Brian Xu; Melinda A Brindley
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.